刺突

cì tū
  • furcella
刺突刺突
刺突[cì tū]
  1. SARS冠状病毒刺突蛋白编码基因及氨基酸序列的同源性分析

    Homologous analysis of SARS-coronavirus spike protein encoding gene and amino acid sequence

  2. SARS冠状病毒刺突蛋白的研究进展

    Research advances in spike glycoprotein of SARS associated coronavirus

  3. 重组SARS-CoV刺突蛋白基因片段的原核表达及纯化

    Over-expression and purification of recombinant spike protein fragment of SARS coronavirus

  4. SARS-CoV刺突蛋白受体结合区的表达及高潜在中和性人源抗体的制备

    Expression of Receptor-binding Domain of SARS-CoV Spike Protein and Isolation of Highly Potent Neutralizing Antibody

  5. 严重急性呼吸综合征患者核壳蛋白和刺突蛋白S1区的特异性抗体研究

    Specific antibodies against the nucleocapsid protein and S 1 domain of spike glycoprotein in patients with severe acute respiratory syndrome

  6. 目的:冠状病毒(SARS-CoV)的刺突蛋白(Spikeglycoprotein,S蛋白)是病毒的主要结构蛋白之一,也是重要的病毒抗原,重组S蛋白的表达可用于检测病毒感染后血清抗体。

    Objective : To obtain the spike glycoprotein ( S protein ) of SARS coronavirus ( SARS-Cov ) for detection of the corresponding antibody and preparation of diagnostic kits .

  7. 结论预测的SARS冠状病毒S2刺突蛋白B细胞表位肽能够诱导家兔产生针对S2蛋白的抗体,为研制抗SARS病毒基因工程疫苗奠定了基础。

    CONCLUSION : The predicted B cell epitope peptide of SARS coronavirus S2 spike protein can induce the antigenicity of S2 protein , which provides some fundamental data for developing engineering vaccine against SARS coronavirus infection .

  8. 目的探讨板蓝根抗内毒素活性部位F022对脂多糖(LPS)刺激小鼠组织膜结构伸展刺突蛋白mRNA(moesinmRNA)表达的影响。

    Objective To probe into the effect of the anti-endotoxic part in Radix Isatidis on the expression of moesin mRNA in tissues of mice induced by lipopolysaccharide ( LPS ) .

  9. 目的探讨SARS冠状病毒的刺突(spike,S)蛋白的免疫学特性,以及S蛋白作为SARS-CoV病毒疫苗组分的可行性。

    Objective To study the immunological characteristics of the spike ( S ) protein of SARS coronavirus ( SARS-CoV ) and analyze the feasibility of using this protein as the component for SARS vaccine development .

  10. 方法:用间接ELISA法检测人和哺乳动物血清SARS冠状病毒(SARS-CoV)核衣壳蛋白(H)和刺突糖蛋白S1片段(S1)IgG滴度,并测定相应抗体的总亲和力。

    Methods : Serum samples of healthy contact persons and mammals were detected with indirect ELISA for the titers and relative affinities of SARS-CoV nucleocapsid protein ( H ) and spike glycoprotein fragment 1 ( S1 ) IgG .

  11. 目的:SARS冠状病毒表面的刺突蛋白(Spike,S蛋白)可与宿主细胞上的病毒受体血管紧张素转化酶2(Angiotensin-ConvertingEnzyme2,ACE2)结合,介导病毒进入细胞。

    AIMS : The spike protein ( S protein ) on the surface of SARS coronavirus can induce virus entering into the host cell by means of binding to the Angiotensin-converting enzyme 2 ( ACE2 ), the virus receptor on the cell .

  12. 禽流感病毒利用一种被称为血凝素蛋白的“棒棒糖形状”的刺突去入侵鼻和肺细胞。

    The flu virus uses a " lollipop-shaped " spike known as hemagglutinin to invade nose and lung cells .

  13. 这种刺突的尖端不断变异,这意味着流感疫苗必须每年重新修改。

    The tip of the spike mutates continually , which means that flu vaccines must be redefined every year .

  14. 一旦附着于其上,抗体就阻止了刺突把病毒的基因注入人类细胞,让它无法复制。

    Once attached , the antibodies prevent the spike from injecting the virus 's genes into human cells , rendering it unable to replicate .

  15. Ⅰ.PPARγ与小分子以及相关受体蛋白的相互作用研究Ⅱ.SARS冠状病毒刺突蛋白免疫片段的热力学和动力学研究

    ⅰ . Interaction between PPAR γ and Ligands or Relative Nuclear Receptor ⅱ . Thermodynamic and Kinetic Investigation of SARS_CoV Spike Glycoprotein Immunological Fragment

  16. 冠状病毒也不例外,是通过其包膜糖蛋白-刺突(S)蛋白与宿主细胞表面受体结合后引起膜融合的;S蛋白在病毒包膜表面形成了冠状病毒特征性的突起,大而明显。

    The envelope glycoproteins , spike ( S ) glycoproteins , of coronaviruses are no exception and mediate binding to host cells followed by membrane fusion ;

  17. 这组科学家回避了这个问题,发现了一个接触非变异的刺突颈部的方法,并且选出了可以附著于其上的抗体。

    The team have sidestepped this by finding a way to expose the non-mutating neck of the spike and selecting antibodies that can attach themselves to it .

  18. 身体乌黑或淡红色。八条触手上列满吸盘,还有一排排名为腕丝的柔软肉质刺突,类似章鱼。

    Jet black to pale red in color , eight arms lined with suction cups and rows of soft fleshy spines known as cirri . , like an octopus .

  19. 对其他种类冠状病毒的研究结果显示,刺突蛋白(S蛋白)和膜蛋白(M蛋白)是病毒主要的结构蛋白。

    Studies on other species of coronaviruses indicated that the spike protein ( S protein ) and membrane protein ( M protein ) are the main structural proteins of the virus .